The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants Richard J. GrallaFausto RoilaMaurizio Tonato Original Article 17 December 2004 Pages: 77 - 79
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an update Steven M. GrunbergDavid OsobaMaurizio Tonato Review Article 14 December 2004 Pages: 80 - 84
Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy Mark G. KrisPaul J. HeskethEnzo Ballatori Review Article 23 November 2004 Pages: 85 - 96
Acute emesis: moderately emetogenic chemotherapy Jørn HerrstedtJim M. KoellerMario Dicato Review Article 23 November 2004 Pages: 97 - 103
Delayed emesis: moderately emetogenic chemotherapy Fausto RoilaDavid WarrJorn Herrstedt Review Article 12 November 2004 Pages: 104 - 108
Emesis induced by low or minimal emetic risk chemotherapy Maurizio TonatoRebecca A. Clark-SnowSussanne Borjeson Review Article 18 November 2004 Pages: 109 - 111
Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement Lawrence H. EinhornBernardo RapoportMatti Aapro Review Article 09 October 2004 Pages: 112 - 116
Anticipatory nausea and vomiting Matti S. AaproAlexander MolassiotisIan Olver Original Article 15 December 2004 Pages: 117 - 121
Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines Petra Ch. FeyerErnesto MaranzanoIan Olver Review Article 08 December 2004 Pages: 122 - 128
Antiemetics in children receiving chemotherapy Fausto RoilaPetra FeyerAlexander Molassiotos Review Article 05 November 2004 Pages: 129 - 131
Antiemetics in children receiving chemotherapy Fausto RoilaPetra FeyerAlexander Molassiotis Erratum 25 January 2005 Pages: 132 - 132